FMP

FMP

Enter

SYK - Stryker Corporation

photo-url-https://images.financialmodelingprep.com/symbol/SYK.png

Stryker Corporation

SYK

NYSE

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

378.22 USD

4.23 (1.12%)

SYK Financial Statements

Year

2024

2023

2022

2021

Current Assets

14.85B

12.52B

10.28B

10.02B

Cash & Short Term Investments

4.49B

3.05B

1.93B

3.02B

Cash And Cash Equivalents

3.65B

2.97B

1.84B

2.94B

Short Term Investments

841M

82M

84M

75M

Net Receivables

3.99B

3.77B

3.56B

3.02B

Inventory

4.77B

4.84B

4B

3.31B

Other Current Assets

1.59B

857M

787M

662M

Non-Current Assets

28.12B

27.39B

26.61B

24.61B

Property, Plant & Equipment

3.45B

3.21B

2.97B

2.83B

Goodwill And Intangible Assets

20.25B

19.84B

19.77B

17.76B

Goodwill

15.86B

15.24B

14.88B

12.92B

Intangible Assets

4.39B

4.59B

4.88B

4.84B

Long Term Investments

0

496M

90M

66M

Tax Assets

1.74B

1.67B

1.41B

1.76B

Other Non-Current Assets

2.68B

2.67B

2.37B

2.2B

Other Assets

0

0

0

0

Total Assets

42.97B

39.91B

36.88B

34.63B

-

-

-

-

Current Liabilities

7.62B

7.92B

6.3B

4.55B

Accounts Payable

1.68B

1.52B

1.41B

1.13B

Short Term Debt

1.41B

2.09B

1.19B

7M

Tax Payables

539M

391M

292M

192M

Deferred Revenue

0

0

0

0

Other Current Liabilities

1.4B

747M

2.14B

2.02B

Total Current Liabilities

7.62B

7.92B

6.3B

4.55B

Total Non-Current Liabilities

14.72B

13.4B

13.96B

15.21B

Long-Term Debt

12.19B

10.9B

11.86B

12.47B

Deferred Revenue

0

0

-67M

-68M

Deferred Taxes Liabilities

0

0

67M

68M

Other Non Current liabilities

2.53B

2.14B

1.75B

2.42B

Total Liabilities

22.34B

21.32B

20.27B

19.75B

Other Liabilities

0

0

0

0

Stockholders Equity

20.63B

18.59B

16.62B

14.88B

Common Stock

38M

38M

38M

38M

Retained Earnings

18.53B

16.77B

14.77B

13.48B

Accumulated Other Comprehensive Income/Loss

-293M

-416M

-221M

-531M

Other Shareholders Equity

2.36B

0

0

0

Total Liabilities and Stockholders Equity

42.97B

39.91B

36.88B

34.63B

Retained Earning Schedule

Year

2024

2023

2022

2021

Retained Earnings (Previous Year)

16.77B

14.77B

13.48B

12.46B

Net Income

2.99B

3.17B

2.36B

1.99B

Stock Repurchases

0

-155M

-122M

-114M

Dividend Paid

-1.22B

-1.14B

-1.05B

-950M

Retained Earnings

18.53B

16.77B

14.77B

13.48B

Other Distributions

538M

712M

112M

-46M

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

3.45B

3.21B

2.97B

2.83B

Annual Depreciation

1.05B

1.03B

998M

990M

Capital Expenditure

-755M

-575M

-588M

-525M

Net PPE

3.15B

2.76B

2.56B

2.37B

Intangible and Goodwill Schedule

Year

2024

2023

2022

2021

Acquisitions and Adjustments

612M

363M

1.96B

140M

Goodwill (Previous Year)

15.24B

14.88B

12.92B

12.78B

Goodwill

15.86B

15.24B

14.88B

12.92B

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep